129 related articles for article (PubMed ID: 17326276)
1. Carbocisteine: frequent cutaneous adverse effects.
Prescrire Int; 2007 Feb; 16(87):17. PubMed ID: 17326276
[TBL] [Abstract][Full Text] [Related]
2. The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.
Hooper C; Calvert J
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):659-69. PubMed ID: 19281081
[TBL] [Abstract][Full Text] [Related]
3. Maculopapular rash to S-carboxymethylcysteine-lysine (carbocisteine).
Gomez Torrijos E; Gratacós Gómez AR; Extremera Ortega AM; Gonzalez Jimenez OM; Romo JBJ; Cañas AP; Rodriguez RG
Contact Dermatitis; 2020 Oct; 83(4):313-314. PubMed ID: 32356398
[No Abstract] [Full Text] [Related]
4. [Fixed drug eruption and carbocysteine].
Schmutz JL; Barbaud A; Trechot P
Ann Dermatol Venereol; 2005 Apr; 132(4):403. PubMed ID: 15886580
[No Abstract] [Full Text] [Related]
5. Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.
Tatsumi K; Fukuchi Y;
J Am Geriatr Soc; 2007 Nov; 55(11):1884-6. PubMed ID: 17979906
[No Abstract] [Full Text] [Related]
6. Carbocisteine for acute exacerbations of COPD.
Waller P; Suissa S
Lancet; 2008 Nov; 372(9650):1630; author reply 1631-2. PubMed ID: 18994655
[No Abstract] [Full Text] [Related]
7. Fixed drug eruption occurring in vitiliginous skin.
Ota M; Tanimura S
J Am Acad Dermatol; 2013 Dec; 69(6):e302-3. PubMed ID: 24238187
[No Abstract] [Full Text] [Related]
8. Theory and practice of the use of expectorants reviewed from clinical aspects.
Nagy G
Ther Hung; 1984; 32(1):6-12. PubMed ID: 6400475
[No Abstract] [Full Text] [Related]
9. [Effects of carbocisteine on airway inflammation and related events in SO2-exposed rats].
Ishibashi Y; Okamura T; Masumoto Y; Tachiiri T; Momo K
Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):17-23. PubMed ID: 11296380
[TBL] [Abstract][Full Text] [Related]
10. [Mucolytic agents. Polycentric study of a carbocysteine-sobrerol combination].
Gramiccioni E; Pamparana F; Messa A
Arch Monaldi Mal Torace; 1989; 44(4-6):791-3. PubMed ID: 2577796
[No Abstract] [Full Text] [Related]
11. Carbocisteine can scavenge reactive oxygen species in vitro.
Nogawa H; Ishibashi Y; Ogawa A; Masuda K; Tsubuki T; Kameda T; Matsuzawa S
Respirology; 2009 Jan; 14(1):53-9. PubMed ID: 19144049
[TBL] [Abstract][Full Text] [Related]
12. Long-term oral carbocisteine therapy in patients with chronic bronchitis. A double blind trial with placebo control.
Grillage M; Barnard-Jones K
Br J Clin Pract; 1985 Oct; 39(10):395-8. PubMed ID: 3907681
[No Abstract] [Full Text] [Related]
13. Drug fever due to S-carboxymethyl-L-cystein: demonstration of a causative agent with patch tests.
Hatakeyama M; Fukunaga A; Shimizu H; Oka M; Horikawa T; Nishigori C
J Dermatol; 2012 Jun; 39(6):555-6. PubMed ID: 21950673
[No Abstract] [Full Text] [Related]
14. [Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem?].
Chalumeau M; Chéron G; Assathiany R; Moulin F; Bavoux F; Bréart G; Pons G
Arch Pediatr; 2002 Nov; 9(11):1128-36. PubMed ID: 12503503
[TBL] [Abstract][Full Text] [Related]
15. Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey.
Mallet P; Mourdi N; Dubus JC; Bavoux F; Boyer-Gervoise MJ; Jean-Pastor MJ; Chalumeau M
PLoS One; 2011; 6(7):e22792. PubMed ID: 21818391
[TBL] [Abstract][Full Text] [Related]
16. Carbocisteine inhibits oxidant-induced apoptosis in cultured human airway epithelial cells.
Yoshida M; Nakayama K; Yasuda H; Kubo H; Kuwano K; Arai H; Yamaya M
Respirology; 2009 Sep; 14(7):1027-34. PubMed ID: 19664007
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of serous and puruloid bronchial hypersecretions in acute and chronic bronchopneumopathies: our experience with a new mucolytic drug].
Fossati C
Clin Ter; 1975 Jul; 74(1):63-82. PubMed ID: 770054
[No Abstract] [Full Text] [Related]
18. A definite case of (L)-carbocisteine-induced pneumonia with CATCH22 syndrome.
Kudo K; Ichihara E; Hisamoto A; Hotta K; Miyahara N; Tanimoto Y; Akagi S; Kato K; Tanimoto M; Kiura K
Intern Med; 2013; 52(1):97-100. PubMed ID: 23291681
[TBL] [Abstract][Full Text] [Related]
19. L-carbocisteine reduces neutrophil elastase-induced mucin production.
Yasuo M; Fujimoto K; Imamura H; Ushiki A; Kanda S; Tsushima K; Kubo H; Yamaya M; Kubo K
Respir Physiol Neurobiol; 2009 Jun; 167(2):214-6. PubMed ID: 19394453
[TBL] [Abstract][Full Text] [Related]
20. S-Carboxymethyl-L-cysteine-induced Fixed Drug Eruption.
Fukuda H; Takahashi M
Acta Derm Venereol; 2019 Jun; 99(7):689-690. PubMed ID: 30938829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
